AMICUS THERAPEUTICS INC (FOLD) Stock Analyst Earnings Estimates
NASDAQ:FOLD - Nasdaq - US03152W1099 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 329.2M 7.76% | 399.356M 21.31% | 528.295M 32.29% | 649.96M 23.03% | 798.05M 22.78% | 980.76M 22.89% | 1.203B 22.66% | 1.391B 15.63% | 1.57B 12.87% | 1.792B 14.14% | 1.723B -3.85% | |
| EBITDA YoY % growth | -200.16M 0.01% | -68.204M 65.93% | 42.611M 162.48% | 124.73M 192.72% | 236.26M 89.42% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -205.5M 0.44% | -76.077M 62.98% | 34.064M 144.78% | 95.193M 179.45% | 205M 115.35% | 421.02M 105.38% | 575.96M 36.80% | 737.66M 28.07% | 887.16M 20.27% | 1.142B 28.73% | 1.067B -6.57% | |
| Operating Margin | -62.42% | -19.05% | 6.45% | 14.65% | 25.69% | 42.93% | 47.88% | 53.03% | 56.51% | 63.73% | 61.93% | |
| EPS YoY % growth | -0.82 10.87% | -0.51 37.80% | -0.14 72.55% | 0.12 183.38% | 0.45 281.57% | 1.10 148.08% | 1.84 66.62% | 2.83 53.46% | 3.44 21.66% | 3.66 6.53% | 3.80 3.90% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.02 88.16% | 0.02 137.88% | 0.04 311.29% | 0.09 -4.80% | 0.03 261.55% | 0.06 223.10% | 0.11 165.51% | 0.15 78.57% | 0.22 633.33% | 0.24 300.00% | 0.28 145.45% |
| Revenue Q2Q % growth | 142.58M 29.15% | 155.86M 23.05% | 169.1M 19.49% | 182.28M 21.76% | 175.1M 22.81% | 189.36M 21.49% | 205.25M 21.38% | 221.61M 21.58% | 201.96M 15.34% | 233.58M 23.35% | 221.34M 7.84% |
| EBITDA Q2Q % growth | 6.599M 133.80% | 19.003M -1.55% | 29.794M -4.84% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 8.506M 139.24% | 21.187M 41.56% | 28.875M 16.42% | 40.412M 153.03% | 21.792M 156.20% | 32.795M 54.79% | 46.122M 59.73% | 60.587M 49.92% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 0.09 181.82% | 0.01 | 0.08 | 511.05% |
| Q3 2024 Q2Q % growth | -0.02 71.43% | 0.00 | -0.02 | % |
| Q2 2024 Q2Q % growth | -0.05 66.67% | -0.06 | 0.01 | 11.61% |
| Q1 2024 Q2Q % growth | -0.16 11.11% | -0.07 | -0.09 | -139.27% |
| Q4 2023 Q2Q % growth | -0.11 42.11% | -0.06 | -0.05 | -83.13% |
| Q3 2023 Q2Q % growth | -0.07 41.67% | -0.08 | 0.01 | 9.17% |
| Q2 2023 Q2Q % growth | -0.15 28.57% | -0.13 | -0.02 | -19.24% |
| Q1 2023 Q2Q % growth | -0.18 40.00% | -0.15 | -0.03 | -20.32% |
| Q4 2022 Q2Q % growth | -0.19 34.48% | -0.13 | -0.06 | -47.42% |
| Q3 2022 Q2Q % growth | -0.12 36.84% | -0.19 | 0.07 | 36.87% |
| Q2 2022 Q2Q % growth | -0.21 -10.53% | -0.22 | 0.01 | 5.12% |
| Q1 2022 Q2Q % growth | -0.30 -20.00% | -0.26 | -0.04 | -15.34% |
| Q4 2021 Q2Q % growth | -0.29 -7.41% | -0.16 | -0.13 | -82.25% |
| Q3 2021 Q2Q % growth | -0.19 17.39% | -0.17 | -0.02 | -10.76% |
| Q2 2021 Q2Q % growth | -0.19 5.00% | -0.22 | 0.03 | 11.86% |
| Q1 2021 Q2Q % growth | -0.25 26.47% | -0.24 | -0.01 | -4.30% |
| Q4 2020 Q2Q % growth | -0.27 22.86% | -0.22 | -0.05 | -21.91% |
| Q3 2020 Q2Q % growth | -0.23 4.17% | -0.22 | -0.01 | -2.89% |
| Q2 2020 Q2Q % growth | -0.20 44.44% | -0.27 | 0.07 | 24.68% |
| Q1 2020 Q2Q % growth | -0.34 12.82% | -0.29 | -0.05 | -17.65% |
| Q4 2019 Q2Q % growth | -0.35 | -0.28 | -0.07 | -25.69% |
| Q3 2019 Q2Q % growth | -0.24 | -0.33 | 0.09 | 26.45% |
| Q2 2019 Q2Q % growth | -0.36 | -0.33 | -0.03 | -8.41% |
| Q1 2019 Q2Q % growth | -0.39 | -0.31 | -0.08 | -23.86% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 149.71M 30.09% | 150.97M | -1.26M | -0.83% |
| Q3 2024 Q2Q % growth | 141.517M 36.73% | 138.04M | 3.477M | 2.52% |
| Q2 2024 Q2Q % growth | 126.669M 34.04% | 123.67M | 2.999M | 2.43% |
| Q1 2024 Q2Q % growth | 110.403M 27.97% | 113.41M | -3.007M | -2.65% |
| Q4 2023 Q2Q % growth | 115.082M 30.63% | 116.62M | -1.538M | -1.32% |
| Q3 2023 Q2Q % growth | 103.501M 26.68% | 103.39M | 111K | 0.11% |
| Q2 2023 Q2Q % growth | 94.503M 17.10% | 91.665M | 2.838M | 3.10% |
| Q1 2023 Q2Q % growth | 86.27M 9.62% | 84.745M | 1.525M | 1.80% |
| Q4 2022 Q2Q % growth | 88.1M 7.18% | 88.015M | 85K | 0.10% |
| Q3 2022 Q2Q % growth | 81.7M 2.77% | 85.905M | -4.205M | -4.89% |
| Q2 2022 Q2Q % growth | 80.7M 4.26% | 87.608M | -6.908M | -7.89% |
| Q1 2022 Q2Q % growth | 78.7M 18.52% | 78.678M | 22K | 0.03% |
| Q4 2021 Q2Q % growth | 82.2M 16.43% | 84.945M | -2.745M | -3.23% |
| Q3 2021 Q2Q % growth | 79.5M 17.95% | 81.716M | -2.216M | -2.71% |
| Q2 2021 Q2Q % growth | 77.4M 24.04% | 74.854M | 2.546M | 3.40% |
| Q1 2021 Q2Q % growth | 66.4M 9.75% | 73.083M | -6.683M | -9.14% |
| Q4 2020 Q2Q % growth | 70.6M 27.67% | 71.459M | -859K | -1.20% |
| Q3 2020 Q2Q % growth | 67.4M 38.11% | 66.4M | 1M | 1.51% |
| Q2 2020 Q2Q % growth | 62.4M 41.50% | 63.631M | -1.231M | -1.93% |
| Q1 2020 Q2Q % growth | 60.5M 77.94% | 58.645M | 1.855M | 3.16% |
| Q4 2019 Q2Q % growth | 55.3M | 53.376M | 1.924M | 3.60% |
| Q3 2019 Q2Q % growth | 48.8M | 48.611M | 189K | 0.39% |
| Q2 2019 Q2Q % growth | 44.1M | 41.956M | 2.144M | 5.11% |
| Q1 2019 Q2Q % growth | 34M | 38.621M | -4.621M | -11.96% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -549.3% | -223.8% | -21.62% | -40.46% |
| Revenue | -1.56% | -3.36% | -0.08% | -0.21% |